CSIMarket
 


Laboratory Corporation Of America Holdings  (LH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

LH's Net Income Growth by Quarter and Year

Laboratory Of America Holdings's Net Income results by quarter and year




LH Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 76.40 553.60 938.60
III Quarter September - 353.20 587.80 703.70
II Quarter June 189.10 358.90 468.00 231.60
I Quarter March 213.30 492.10 770.10 -316.90
FY   402.40 1,280.60 2,379.50 1,557.00



LH Net Income second quarter 2023 Y/Y Growth Comment
Laboratory Corporation Of America Holdings reported drop in Net Income in the second quarter 2023 by -47.31% to $ 189.10 millions, from the same quarter in 2022.
The fall in the second quarter 2023 Laboratory Corporation Of America Holdings's Net Income compares unfavorably to the Company's average Net Income rise of 28.11%.

Looking into second quarter 2023 results within Medical Laboratories industry 5 other companies have achieved higher Net Income growth. While Laboratory Corporation Of America Holdings' s Net Income meltdown of -47.31% ranks overall at the positon no. 1202 in the second quarter 2023.




LH Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -86.2 % -41.02 % 312.93 %
III Quarter September - -39.91 % -16.47 % 218.42 %
II Quarter June -47.31 % -23.31 % 102.07 % 21.45 %
I Quarter March -56.66 % -36.1 % - -
FY   - -46.18 % 52.83 % 88.75 %

Financial Statements
Laboratory Of America Holdings's second quarter 2023 Net Income $ 189.10 millions LH's Income Statement
Laboratory Of America Holdings's second quarter 2022 Net Income $ 358.90 millions Quarterly LH's Income Statement
New: More LH's historic Net Income Growth >>


LH Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -78.37 % -5.82 % 33.38 %
III Quarter September - -1.59 % 25.6 % 203.84 %
II Quarter June -11.35 % -27.07 % -39.23 % -
I Quarter March 179.19 % -11.11 % -17.95 % -
FY (Year on Year)   - -46.18 % 52.83 % 88.75 %




Net Income second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #6
Healthcare Sector #66
Overall #1202

Net Income Y/Y Growth Statistics
High Average Low
720.86 % 28.11 % -76.5 %
(Mar 31 2021)   (Dec 31 2013)
Net Income second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #6
Healthcare Sector #66
Overall #1202
Net Income Y/Y Growth Statistics
High Average Low
720.86 % 28.11 % -76.5 %
(Mar 31 2021)   (Dec 31 2013)

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Laboratory Of America Holdings's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
16770 % 251.14 % -99.16 %
(Jun 30 2015)  


LH's II. Quarter Q/Q Net Income Comment
In the II. Quarter 2023 Laboratory Corporation Of America Holdings disclosed drop in Net Income sequentially by -11.35% to $ 189.10 millions, from $ 213.30 millions declared in the previous reporting period.

If you look into recent shortcoming at the II. Quarter, you should presume, that frequently II. Quarter Net Income emerge weaker relative to the quarter before, Alexander Jacobs, Healthcare sector advisor from Frankfurt added.

Within Medical Laboratories industry 7 other companies have achieved higher Net Income quarter on quarter growth. While Laboratory Of America Holdings's Net Income growth quarter on quarter, overall rank is 1273.


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #8
Healthcare Sector #96
Overall #1273
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #8
Healthcare Sector #96
Overall #1273
Net Income Q/Q Growth Statistics
High Average Low
16770 % 251.14 % -99.16 %
(Jun 30 2015)  


LH's II. Quarter Q/Q Net Income Comment
In the II. Quarter 2023 Laboratory Corporation Of America Holdings reported drop in Net Income sequentially by -11.35% to $ 189.10 millions, from $ 213.30 millions achived in the previous reporting period.

This is not huge issue, as Laboratory Of America Holdings's Net Income frequently gravitate to slow in this quarter.

Within Medical Laboratories industry 7 other companies have achieved higher Net Income quarter on quarter growth. While Laboratory Of America Holdings's Net Income growth quarter on quarter, overall rank is 1273.


Laboratory Of America Holdings's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Net Income 12 Months Ending $ 1,280.60 $ 1,757.80 $ 1,992.40 $ 2,101.50 $ 2,379.50
Y / Y Net Income Growth (TTM) -46.18 % -36.42 % -30.83 % -20.52 % 52.83 %
Year on Year Net Income Growth Overall Ranking # 367 # 452 # 331 # 1461 # 684
Seqeuential Net Income Change (TTM) -27.15 % -11.77 % -5.19 % -11.68 % -13.93 %
Seq. Net Income Growth (TTM) Overall Ranking # 1202 # 1363 # 1106 # 1763 # 626




Cumulative Net Income growth Comment
Laboratory Of America Holdings's cumulative 12 months Net Income continue to drop, but on the faster rate at -46.18% year on year, at Dec 31 2022 compare to the -36.42% decrease at Sep 30 2022. If the Laboratory Of America Holdings's fiscal year would end at Dec 31 2022, annual Net Income would be $1,281 millions.

Among companies within the Healthcare sector 19 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 367, from total ranking in previous quarter at 452.

Net Income TTM Q/Q Growth Statistics
High Average Low
720.86 %
28.11 %
-76.5 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 6
Healthcare Sector # 20
Overall # 367

Net Income TTM Y/Y Growth Statistics
High Average Low
720.86 %
28.11 %
-76.5 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 66
S&P 500 # 1202
Cumulative Net Income growth Comment
Laboratory Of America Holdings's cumulative 12 months Net Income continue to drop, but on the faster rate at -46.18% year on year, at Dec 31 2022 compare to the -36.42% decrease at Sep 30 2022. If the Laboratory Of America Holdings's fiscal year would end at Dec 31 2022, annual Net Income would be $1,281 millions.

Among companies within the Healthcare sector 19 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 367, from total ranking in previous quarter at 452.

Net Income TTM Q/Q Growth Statistics
High Average Low
720.86 %
28.11 %
-76.5 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 6
Healthcare Sector # 20
Overall # 367

Net Income TTM Y/Y Growth Statistics
High Average Low
720.86 %
28.11 %
-76.5 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 66
S&P 500 # 1202




Other Net Income Growth
Medical Laboratories Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
LH's Net Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for LH's Competitors
Net Income Growth for Laboratory Of America Holdings's Suppliers
Net Income Growth for LH's Customers

You may also want to know
LH's Annual Growth Rates LH's Profitability Ratios LH's Asset Turnover Ratio LH's Dividend Growth
LH's Roe LH's Valuation Ratios LH's Financial Strength Ratios LH's Dividend Payout Ratio
LH's Roa LH's Inventory Turnover Ratio LH's Growth Rates LH's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2023
Corcept Therapeutics Inc-0.15%$ -0.153 millions
Quest Diagnostics Inc-0.40%$ -0.400 millions
Align Technology inc -0.87%$ -0.874 millions
Adapthealth Corp -1.35%$ -1.351 millions
U S Physical Therapy Inc-2.57%$ -2.569 millions
Prestige Consumer Healthcare Inc -3.31%$ -3.313 millions
Dariohealth Corp -8.00%$ -8.004 millions
Gilead Sciences Inc -8.46%$ -8.458 millions
Acadia Healthcare Company Inc -10.23%$ -10.232 millions
National Research Corporation-12.61%$ -12.605 millions
Davita Inc -13.44%$ -13.435 millions
Biomx Inc -14.31%$ -14.314 millions
Viatris Inc -15.90%$ -15.897 millions
West Pharmaceutical Services Inc -17.72%$ -17.719 millions
Chemed Corporation-19.68%$ -19.681 millions
Sotera Health Company-22.70%$ -22.700 millions
Edwards Lifesciences Corporation-24.83%$ -24.828 millions
Royalty Pharma Plc-28.53%$ -28.532 millions
Atrion Corporation-29.79%$ -29.792 millions
Abbott Laboratories-31.86%$ -31.863 millions
Orgenesis Inc -33.34%$ -33.339 millions
Hh and l Acquisition Co -33.56%$ -33.559 millions
Carlisle Companies Incorporated-35.46%$ -35.456 millions
Organogenesis Holdings Inc -39.20%$ -39.204 millions
Vanda Pharmaceuticals Inc -40.95%$ -40.948 millions
Biogen Inc -43.96%$ -43.960 millions
Laboratory Corporation Of America Holdings-47.31%$ -47.311 millions
Lftd Partners Inc -48.46%$ -48.455 millions
Repligen Corp-59.76%$ -59.760 millions
Tenax Therapeutics Inc -61.33%$ -61.331 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com